Seasonal Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Seasonal Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-06-17Clinical Trial Update: Follow-up Investigation of Efficacy of Ragweed MATAMPL,and Placebo in Patients With Ragweed-induced Seasonal Allergic Rhinitis [Phase 2]
Phase 2 clinical trial evaluating Ragweed MATAMPL versus placebo for ragweed-induced seasonal allergic rhinitis has completed follow-up asse…
-
CLINICAL_TRIALS trial_result · 2010-06-16Clinical Trial Update: Montelukast in Seasonal Allergic Rhinitis - Spring 2001 Study (0476-235) [Phase 3]
Phase 3 trial update for montelukast in seasonal allergic rhinitis; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2010-06-16Clinical Trial Update: Montelukast in Seasonal Allergic Rhinitis - Fall 1999 Study (0476A-117) [Phase 3]
Phase 3 trial update for montelukast in seasonal allergic rhinitis completed with results posted.
-
CLINICAL_TRIALS trial_result · 2010-06-09Clinical Trial Update: Montelukast in Seasonal Allergic Rhinitis: Fall 2001 Study (0476-240) [Phase 3]
Phase 3 clinical trial update for montelukast in seasonal allergic rhinitis; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2010-06-09Clinical Trial Update: A Study Investigating the Effect of Montelukast in Patients With Seasonal Allergic Rhinitis (MK-0476-192)(COMPLETED) [Phase 3]
Phase 3 trial investigating montelukast for seasonal allergic rhinitis has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-06-08Clinical Trial Update: Montelukast in Patients With Seasonal Allergic Rhinitis - Spring 2000 Study (MK-0476A-162)(COMPLETED) [Phase 3]
Phase 3 trial update for montelukast in seasonal allergic rhinitis completed with results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-06-02Clinical Trial Update: A Study To Explore The Effect On Inflammatory Markers After Nasal Allergen Challenge In Subjects With Seasonal Allergic Rhinitis And The Effect Of A Single Dose Of Ibuprofen Or Fluticasone Propionate On The Allergen Response. [Phase 1]
Phase 1 trial assessing the effect of a single dose of ibuprofen or fluticasone propionate on inflammatory markers and allergen response aft…
-
CLINICAL_TRIALS trial_result · 2010-05-31Clinical Trial Update: Pilot Study of Allergy Immunotherapy and Prevention of Viral Respiratory Infections
Pilot clinical trial update evaluating allergy immunotherapy for prevention of viral respiratory infections in individuals with allergic rhi…
-
CLINICAL_TRIALS trial_result · 2010-05-17Clinical Trial Update: Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg Once Daily (QD) in the Treatment of Seasonal Allergic Rhinitis (Study P05067)(COMPLETED) [Phase 3]
A completed Phase 3 placebo-controlled trial evaluating mometasone furoate nasal spray (MFNS) 200 mcg daily for seasonal allergic rhinitis w…
-
FDA label_change · 2010-04-26FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Singulair (montelukast) from Organon LLC, indicating a labeling change associated with the p…
-
CLINICAL_TRIALS trial_result · 2010-04-21Clinical Trial Update: Comparison of Seasonal Allergic Rhinitis Treatment With 2 Antihistamines Used in Combination With Intranasal Corticosteroid [Phase 4]
Phase 4 clinical trial comparing two antihistamines used in combination with an intranasal corticosteroid for seasonal allergic rhinitis. Re…
-
CLINICAL_TRIALS trial_result · 2010-04-05Clinical Trial Update: Efficacy and Safety of Lectranal® in Treatment of Seasonal Allergic Rhinitis Symptoms [Phase 4]
Phase 4 clinical trial assessing the efficacy and safety of Lectranal for Seasonal Allergic Rhinitis has been completed.
-
CLINICAL_TRIALS trial_result · 2010-04-05Clinical Trial Update: This Study Contains an Active Drug Treatment Group With Mometasone Furoate Nasal Spray and a Placebo (Dummy) Treatment Group for Seasonal Allergic Rhinitis (SAR). (Study P05073)(COMPLETED) [Phase 4]
A Phase 4 trial comparing mometasone furoate nasal spray to placebo for seasonal allergic rhinitis has completed and posted results.
-
FDA approval · 2010-03-17FDA Approved: FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCI — Original Application (Dr.Reddy's Laboratories Limited)
FDA approved Dr. Reddy's Laboratories' original application for a generic fixed-dose combination of fexofenadine HCl and pseudoephedrine HCl…
-
CLINICAL_TRIALS trial_result · 2010-03-15Clinical Trial Update: Efficacy Investigation Study of Olopatadine Hydrochloride Ophthalmic Solution Using OHIO Chamber in Patients With Seasonal Allergic Rhinitis (SAR) [Phase 4]
Phase 4 clinical trial evaluating olopatadine hydrochloride ophthalmic solution in seasonal allergic rhinitis using an OHIO chamber, with re…
-
CLINICAL_TRIALS trial_result · 2010-03-11Clinical Trial Update: Mometasone Furoate on Sleep Disturbances in Subjects With Seasonal Allergic Rhinitis (Study P04608) (COMPLETED) [Phase 4]
Phase 4 trial evaluating mometasone furoate for sleep disturbances in subjects with seasonal allergic rhinitis has completed with results po…
-
CLINICAL_TRIALS trial_result · 2010-03-10Clinical Trial Update: Comparison of Olopatadine 0.6% and Fluticasone Proprionate 50mcg Nasal Sprays in a Two Week Seasonal Allergic Rhinitis Trial [Phase 4]
Phase 4 head-to-head trial comparing olopatadine 0.6% nasal spray with fluticasone propionate 50 mcg nasal spray in seasonal allergic rhinit…
-
CLINICAL_TRIALS trial_result · 2010-02-09Clinical Trial Update: Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients [Phase 3]
Phase 3 study evaluating safety and efficacy of olopatadine hydrochloride nasal spray in children aged 6-11 with Seasonal Allergic Rhinitis …
-
CLINICAL_TRIALS trial_result · 2010-02-03Clinical Trial Update: Study to Assess the Effect of a Combination of Cetirizine With Pseudoephedrine Versus Cetirizine Alone on Symptoms in Patients With Allergic Rhinitis [NA]
A study evaluated whether adding pseudoephedrine to cetirizine improves symptoms in seasonal allergic rhinitis compared with cetirizine alon…
-
CLINICAL_TRIALS trial_result · 2010-01-28Clinical Trial Update: A Study to Evaluate the Safety & Effectiveness of a Nasal Spray to Treat Seasonal Allergies [Phase 3]
A Phase 3 trial evaluating the safety and effectiveness of a nasal spray for seasonal allergic rhinitis has completed, with results posted i…
-
CLINICAL_TRIALS trial_result · 2010-01-28Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies [Phase 3]
This clinical trial update reports results from a Phase 3 study evaluating the safety and effectiveness of a nasal spray for seasonal allerg…
-
CLINICAL_TRIALS trial_result · 2010-01-28Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies [Phase 3]
Phase 3 clinical trial update: a nasal spray developed by Meda Pharmaceuticals for seasonal allergic rhinitis has completed the study with r…
-
FDA approval · 2010-01-25FDA Approved: CLARITIN-D 12 HOUR — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for CLARITIN-D 12 HOUR (loratadine and pseudoephedrine sulfate) from Bayer HealthCare LLC.
-
EMA withdrawal · 2009-12-31EMA Withdrawn: Allex (desloratadine) — Schering-Plough Europe
Desloratadine product Allex (Schering-Plough Europe) has been withdrawn from the market.
-
CLINICAL_TRIALS trial_result · 2009-12-11Clinical Trial Update: A Study Comparing Montelukast With Placebo in Children With Seasonal Allergic Rhinitis (0476-219)(COMPLETED) [Phase 3]
Phase 3 clinical trial comparing montelukast to placebo in children with seasonal allergic rhinitis has completed, with results posted.